Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Go back to Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs| (NASDAQ: JAGX) | Delayed: 1.03 -0.3 (22.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.33 | 52 Week High | $4.60 | |||
| Open | $1.33 | 52 Week Low | $0.81 | |||
| Day High | $1.33 | P/E | N/A | |||
| Day Low | $0.97 | EPS | $0.00 | |||
| Volume | 228,810 | |||||
